Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04993651 · ClinicalTrials.gov registry record · NA
Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
A NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT04993651: Completed NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus, sponsored by Eastern Virginia Medical School.
NCT04993651 is a NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 66 participants, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04993651, a NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus, has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.
Primary Outcome
We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.
Conditions Studied
Interventions
- DEVICE CPAP
Study Locations (1)
Virginia
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT04993651 record still lists
NCT04993651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.
NCT04993651 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04993651 about?
NCT04993651 is a clinical study titled "Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women". The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.
What is the current status of trial NCT04993651?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-10-11. Estimated completion is 2023-06-30.
What conditions does trial NCT04993651 study?
This clinical trial studies the following conditions: Morbid Obesity, Cesarean Delivery Affecting Fetus.
What interventions are being tested in trial NCT04993651?
The interventions under investigation include: CPAP (DEVICE).
Who is sponsoring clinical trial NCT04993651?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04993651 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04993651's enrollment target sits among peer trials
66 13th of 24 higher than 12 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Activity Level Monitoring Study
ACTIVE NOT RECRUITING · NA
-
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates
COMPLETED · NA
-
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
COMPLETED · NA
-
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
COMPLETED · NA
-
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI